All public procurement organizations, especially those with the ability to concentrate market share and impact the competitive environment, must abide by various rules, guidelines, laws, policies and ethical standards imposed by government, the health authorities, provincial law and the general public.
BC Clinical and Support Services (BCCSS) is fully compliant with inter-provincial trade agreements entered into by the Government - Agreement on Internal Trade (AIT), New West Partnership Trade Agreement (NWPTA), and Trade Investment Labour Mobility Agreement (TILMA).
BCCSS, the Ministry of Health and the health authorities participate in the health technology review process which is used to provide evidence-informed recommendations about which new, non-drug health technologies (tools, devices, diagnostics and procedures) should be publicly funded in the province. If a technology fits the scope of the review, a business case will be developed via the Health Technology Review Office, which is then examined by the Health Technology Assessment Committee (HTAC). The HTAC makes funding recommendations to a committee of senior executives in the Ministry of Health and health authorities. For more information, please visit the government’s website
As well, BCCSS has policies in place to inform its business practices, including:
- Fair and Competitive Procurement Policy ensures BC Clinical and Support Services acts in a responsible manner in spending public money.
- Evaluation Criteria Weighting Policy ensures appropriate weighting between clinical quality, financial and business considerations.
- Value Adds Policy defines how BC Clinical and Support Services will request, evaluate, accept and distribute Value Add offerings from vendors.
BCCSS requires all vendors to adhere to BCCSS’ Standards of Conduct as well as policies imposed by the health authorities. Please review the Standards/Conduct Policies as well as the Conflict of Interest Policies on the health organization websites listed below.